Advanced Accelerator Applications SA (AAAP)

81.63
0.13 0.16
NASDAQ : Health Technology
Prev Close 81.50
Open 81.63
Day Low/High 81.50 / 82.05
52 Wk Low/High 35.11 / 82.74
Volume 12.12K
Avg Volume 333.80K
Exchange NASDAQ
Shares Outstanding 44.17M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Advanced Accelerator Applications Announces Completion Of $3.9 Billion Novartis Tender Offer

Advanced Accelerator Applications Announces Completion Of $3.9 Billion Novartis Tender Offer

Novartis Global Oncology Expertise to Enhance Launch of Lutetium Lu 177 Dotatate (LUTATHERA®) and Accelerate Development of Theragnostic Pipeline

Novartis Reportedly Taps Centerview to Evaluate Options for Dermatology Business

Novartis Reportedly Taps Centerview to Evaluate Options for Dermatology Business

The Switzerland-headquartered drug manufacturer is reportedly mulling a sale of its dermatology generics drug unit, which is based primarily in the U.S.

Washington Uncertainty and a Healthcare Selloff Send Stocks Lower

Washington Uncertainty and a Healthcare Selloff Send Stocks Lower

Uncertainty in Washington, D.C., a healthcare sector in selloff mode and a big deals day on Wall Street sent U.S. equities lower to begin the week.

Stocks Burrow Further Into the Red on Logistics of Tax Cut Plan

Stocks Burrow Further Into the Red on Logistics of Tax Cut Plan

Stocks dig further into the red on Monday, Oct. 30, as investors weigh how a proposed phase-in corporate tax rate cut might impact U.S. companies.

Merck Weighs on Dow but Apple and Tech Rally Give Lift to Nasdaq

Merck Weighs on Dow but Apple and Tech Rally Give Lift to Nasdaq

Stocks are mixed on Monday as Mueller's Russia investigation takes its first concrete steps.

Stock Futures Lower as Manafort Told to Surrender in Mueller Probe

Stock Futures Lower as Manafort Told to Surrender in Mueller Probe

Stock futures are lower on Monday as Mueller's Russia investigation takes its first concrete steps.

Novartis, Akzo Nobel and Axalta - 5 Things You Must Know Before the Market Opens

Novartis, Akzo Nobel and Axalta - 5 Things You Must Know Before the Market Opens

U.S. stock futures are lower on Monday.

Novartis To Buy Advanced Accelerator for $3.9 Billion in Oncology Push

Novartis To Buy Advanced Accelerator for $3.9 Billion in Oncology Push

Under the deal Novarits will make a cash offer of $41 a share for Nasdaq-listed AAA and $82 per American Depositary Share, subject to certain conditions, valuing AAA at $3.9 billion

Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer By Novartis

Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer By Novartis

Novartis Oncology Expertise to Facilitate Ongoing Development of Theragnostic Pipeline

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: None Downgrades: AAAP, AEO, ARCC, FSC, WCC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Oversold Conditions For Advanced Accelerator Applications (AAAP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Advanced Accelerator Applications Signs Strategic Supply Agreement With University Of Missouri For Lutetium 177

Strengthens Global Supply Chain for Lead Investigational Product Lutetium Lu 177 Dotatate (Lutathera®) and Future Lu-177 Products

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AAAP, CCO, DM, MU Downgrades: ASYS, EQT, ESRT, INCR, NNI, PANW Initiations: None Read on to get TheStreet Quant Ratings' detailed report: